Author name: mikeatshd

Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunology

Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunology

Vista, CA, March 18, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, and Mountaineer Biosciences today announced the launch of Subtilitas, a precision translational medicine platform designed to bring objective, molecular-level insights into dermatology and immunology clinical research Subtilitas integrates non-invasive skin sampling, advanced molecular profiling, and artificial intelligence/machine

Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunology Read More »

Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™

Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™

Decision brings precision medicine in psoriasis to all 50 states Vista, CA, April 22, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State Department of Health for its Mind.Px test. Mind.Px is a genomic test that utilizes the proprietary

Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™ Read More »